Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 12
- −3 vs. Q4 2024
- Portfolio value
- $5.08M
- −$11.6M (−69.5%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $3.83M | 75.3% | 00.0% | Unchanged | History |
| GLDSPDR Gold Trust | ETF | 1,298 | $374.1K | 7.4% | +129+11.0% | Added | History |
| BRK.BBerkshire Hathaway Inc | Stock | 467 | $248.8K | 4.9% | −666−58.8% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 34,073 | $199.3K | 3.9% | 00.0% | Unchanged | History |
| BCAXBicara Therapeutics Inc. | COM | 10,941 | $142.6K | 2.8% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 43,465 | $82.6K | 1.6% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 17,851 | $61.9K | 1.2% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 22,981 | $44.4K | 0.9% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 13,287 | $41.7K | 0.8% | 00.0% | Unchanged | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 16,393 | $35.9K | 0.7% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 17,488 | $13.2K | 0.3% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 18,403 | $11.3K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (3)
Positions held at the end of Q4 2024 that are gone from this filing.